Abstract
Chorea is characterized by involuntary, brief, unpredictable, and random hyperkinetic movements. This chapter reviews main clinical characteristics of chorea and similar hyperkinetic movements and their most common causes. We describe characteristic phenotypic features of chorea-causing conditions, their differential diagnosis, and most useful clinical work-up, including genetic testing. We also discuss most typical clinical presentation of the most common types of chorea, especially Huntington’s disease with its motor and non-motor symptoms and signs, and main therapeutic options. Additional emphasis is on treatable causes of chorea, such as Sydenham chorea and Wilson’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2003;25:61–78.
Bader B, Vollmar C, Ackl N, Ebert A, la Fougère C, Noachtar S, Danek A. Bilateral temporal lobe epilepsy confirmed with intracranial EEG in chorea-acanthocytosis. Seizure. 2011;20:340–2.
Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M. Chorea in systemic lupus erythematosus. J Clin Rheumatol. 2011;17:69–72.
Breedveld GJ, Percy AK, MacDonald ME, et al. Clinical and genetic heterogeneity in benign hereditary chorea. Neurology. 2002;59:579–84.
Brilot F, Merheb V, Ding A, Murphy T, Dale RC. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology. 2011;76:1508–13.
Cardoso F. Chorea gravidarum. Arch Neurol. 2002;59:868–70.
Cardoso F. Sydenham’s chorea. Handb Clin Neurol. 2011;100:221–9.
Cardoso F, Maia D, Cunningham MC, Valenca G. Treatment of Sydenham chorea with corticosteroids. Mov Disord. 2003;18:1374–7.
Carroll E, Sanchez-Ramos J. Hyperkinetic movement disorders associated with HIV and other viral infections. Handb Clin Neurol. 2011;100:323–34.
Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76:294–300.
Cummins A, Eggert J, Pruitt R, Collins JS. Huntington disease: implications for practice. Nurse Pract. 2011;36:41–7.
Dale RC, Yin K, Ding A, et al. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol. 2011;53:522–8.
de Tommaso M, Serpino C, Sciruicchio V. Management of Huntington’s disease: role of tetrabenazine. Ther Clin Risk Manag. 2011;7:123–9.
Docherty MJ, Burn DJ. Hyperthyroid chorea. Handb Clin Neurol. 2011;100:279–86.
Eidelberg D, Surmeier DJ. Brain networks in Huntington disease. J Clin Invest. 2011;121:484–92.
Em JJ, Chang MK. Hemiballism-hemichorea and non-ketotic hyperglycaemia. J Neurol Neurosurg Psychiatry. 1994;57:748–50.
Goetz CG, Pappert EJ. Textbook of clinical neurology. 2nd ed. Philadelphia: Saunders; 1999.
Hagiwara K, Tominaga K, Okada Y, et al. Post-streptococcal chorea in an adult with bilateral striatal encephalitis. J Clin Neurosci. 2011;18:708–9.
Ikeuchi T, Koide R, Onodera O, et al. Dentatorubral – pallidoluysian atrophy (DRPLA): molecular basis for wide clinical features of DRPLA. Clin Neurosci. 1995;3:23–7.
Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington’s disease. Ann Neurol. 1994;36:630–5.
Inzelberg R, Weinberger M, Gak E. Benign hereditary chorea: an update. Parkinsonism Relat Disord. 2011;17:301–7.
Ishaq S, Khalil S, Khan A, Khalid U. Chorea as an unusual presenting feature of anti-phospholipid syndrome. J Pak Med Assoc. 2010;60:975–6.
Jankovic J, Tolosa E. Parkinson’s disease and movement disorder. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007.
Johri A, Chaturvedi RK, Beal MF. Hugging tight in Huntington’s. Nat Med. 2011;17:245–6.
Kimber TE, Thompson PD. Senile chorea. Handb Clin Neurol. 2011;100:213–7.
Kleiner-Fisman G. Benign hereditary chorea. Handb Clin Neurol. 2011;100:199–212.
Klempíř J, Zidovská J, Stochl J, Ing VK, Uhrová T, Roth J. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington’s disease. Mov Disord. 2011;26:125–9.
Kobayashi K, Aoyama N, Sasaki J, et al. MRI appearance of a cerebral cavernous malformation in the caudate nucleus before and after chorea onset. J Clin Neurosci. 2011;18:719–21.
Kremer HP. Imaging Huntington’s disease (HD) brains – imagine HD trails. Neurol Neurosurg Psychiatry. 2005;76:620.
Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994;330:1401–6.
Kuehn BM. Imaging helps to identify early changes associated with Huntington disease. JAMA. 2011;305:138.
Le Ber I, Camuzat A, Castelnova G, et al. Prevalence of dentatorubral pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. Arch Neurol. 2003;60:1097–9.
Leung JG, Breden EL. Tetrabenazine for the treatment of tardive dyskinesia. Ann Pharmacother. 2011;45:525–31.
Lewin AB, Storch EA, Murphy TK. Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in identical siblings. J Child Adolesc Psychopharmacol. 2011;21:177–82.
Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington’s disease. Neurology. 2000;54:452–8.
Margolis RL, Homes SE, Rosenblatt A, et al. Huntington’s disease like 2 (HDL2) in North America and Japan. Ann Neurol. 2004;56:670–4.
Marshall FJ. A randomized, double blind placebo-controlled study of tetrabenazine in patients with Huntington’s disease. Mov Disord. 2004;19:1122.
Marvi MM, Lew MF. Polycythemia and chorea. Handb Clin Neurol. 2011;100:271–6.
Miyasaki JM. Chorea caused by toxins. Handb Clin Neurol. 2011;100:335–46.
Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest. 2011;121:493–9.
Ondo WG. Hyperglycemic nonketotic states and other metabolic imbalances. Handb Clin Neurol. 2011;100:287–91.
Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;71:310–4.
Paulsen JS, Hoth KF, Nehl C, Stierman L. Critical periods of suicide risk in Huntington’s disease. Am J Psychiatry. 2005;162:725–31.
Perlman SL. Spinocerebellar degenerations. Handb Clin Neurol. 2011;100:113–40.
Piccolo I, Defanti CA, Soliveri P, et al. Cause and course in a series of patients with sporadic chorea. J Neurol. 2003;250:429–35.
Przekop A, Sanger TD. Birth-related syndromes of athetosis and kernicterus. Handb Clin Neurol. 2011;100:387–95.
Przekop A, McClure C, Ashwal S. Postoperative encephalopathy with choreoathetosis. Handb Clin Neurol. 2011;100:295–305.
Ray LW, Koller WC. Movement disorders, neurologic principles and practice. 2nd ed. New York: McGraw-Hill; 1997.
Reglodi D, Kiss P, Lubics A, Tamas A. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des. 2011;17:962–72.
Robottom BJ, Weiner WJ. Chorea gravidarum. Handb Clin Neurol. 2011;100:231–5.
Rolands LP, editor. Merritt’s textbook of neurology. 10th ed. New York: Lippincott Williams & Wilkins; 2000.
Rozas JL, Gómez-Sánchez L, Tomás-Zapico C, Lucas JJ, Fernández-Chacón R. Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease. J Neurosci. 2011;31:1106–13.
Sadeghian H, O'Suilleabhain PE, Battiste J, Elliott JL, Trivedi JR. Huntington chorea presenting with motor neuron disease. Arch Neurol. 2011;68:650–2.
Sah DW, Aronin N. Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest. 2011;121:500–7.
Schneider SA, Bhatia KP. Huntington’s disease look-alikes. Handb Clin Neurol. 2011;100:101–12.
Shirendeb U, Reddy AP, Manczak M, et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington’s disease: implications for selective neuronal damage. Hum Mol Genet. 2011;20:1438–55.
Stemper B, Thurauf N, Neundorfer B, Heckmann JG. Choreoathetosis related to lithium intoxication. Eur J Neurol. 2003;10:743–4.
Stevanin G, Fujigasaki H, Lebre AS, et al. Huntington’s disease like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain. 2003;126:1599–603.
Tani LY, Veasy LG, Minich LL, Shaddy RE. Rheumatic fever in children younger than 5 years; is the presentation different? Pediatrics. 2003;112:1065–8.
Thobois S, Bozio A, Ninet J, Akhavi A, Broussolle E. Chorea after cardiopulmonary bypass. Eur Neurol. 2004;51:46–7.
Walker HK. An overview of the nervous system. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990a. Chapter 50.
Walker HK. Involuntary movements. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990b. Chapter 70.
Walker RH, Rasmussen A, Rudnicki D, et al. Huntington’s disease like 2 can present as chorea acanthocytosis. Neurology. 2003;61:1002–4.
Walker RH, Jung HH, Danek A. Neuroacanthocytosis. Handb Clin Neurol. 2011;100:141–51.
Walterfang M, Evans A, Looi JC, et al. The neuropsychiatry of neuroacanthocytosis syndromes. Neurosci Biobehav Rev. 2011a;35:1275–83.
Walterfang M, Looi JC, Styner M, et al. Shape alterations in the striatum in chorea-acanthocytosis. Psychiatry Res. 2011b;192:29–36.
Zesiewicz TA, Sullivan KL. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents. Handb Clin Neurol. 2011;100:347–63.
Zijlmans JC. Vascular chorea in adults and children. Handb Clin Neurol. 2011;100:261–70.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rana, A.Q., Hedera, P. (2014). Chorea. In: Differential Diagnosis of Movement Disorders in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-01607-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-01607-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01606-1
Online ISBN: 978-3-319-01607-8
eBook Packages: MedicineMedicine (R0)